Kleeman Christopher MD is categorized under Internal Medicine Doctors in Philadelphia, PA and active since 2010.
Kleeman Christopher MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Christopher Kleeman at the company’s single location by writing to 2230 East Allegheny Avenue, Philadelphia, Pennsylvania PA 19134 or by phoning (215) 634-3418. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Kleeman Christopher MD |
| Contact Person: | Christopher Kleeman |
| Address: | 2230 East Allegheny Avenue, Philadelphia, Pennsylvania 19134 |
| Phone Number: | (215) 634-3418 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Kleeman Christopher MD was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Christopher Kleeman for inquiries that concern Kleeman Christopher MD by calling the company number (215) 634-3418, as your correspondence is most welcome. Additionally, the physical location of the single location of Kleeman Christopher MD can be found at the coordinates 39.99038,-75.10807 as well as the street address 2230 East Allegheny Avenue in Philadelphia, Pennsylvania 19134.
For its online presence, you may visit Kleeman Christopher MD’s website at and engage with its social media outlets through on Twitter and on Facebook.